WaveForm Diabetes (formerly AgaMatrix Holdings) Revenue and Competitors
Estimated Revenue & Valuation
- WaveForm Diabetes (formerly AgaMatrix Holdings)'s estimated annual revenue is currently $30.6M per year.
- WaveForm Diabetes (formerly AgaMatrix Holdings)'s estimated revenue per employee is $251,000
- WaveForm Diabetes (formerly AgaMatrix Holdings)'s total funding is $152.2M.
Employee Data
- WaveForm Diabetes (formerly AgaMatrix Holdings) has 122 Employees.
- WaveForm Diabetes (formerly AgaMatrix Holdings) grew their employee count by 0% last year.
WaveForm Diabetes (formerly AgaMatrix Holdings)'s People
Name | Title | Email/Phone |
---|---|---|
1 | President and CEO | Reveal Email/Phone |
2 | VP Engineering | Reveal Email/Phone |
3 | VP Human Resources | Reveal Email/Phone |
4 | VP, Quality Assurance, Regulatory and Clinical Affairs | Reveal Email/Phone |
5 | Director Scientific Development | Reveal Email/Phone |
6 | Director | Reveal Email/Phone |
7 | Manager Financial Planning & Analysis | Reveal Email/Phone |
8 | Diabetes Care Manager | Reveal Email/Phone |
9 | Manager, iOS Development | Reveal Email/Phone |
10 | Diabetes Care Manager | Reveal Email/Phone |
WaveForm Diabetes (formerly AgaMatrix Holdings) Competitors & AlternativesAdd Company
Competitor Name | Revenue | Number of Employees | Employee Growth | Total Funding | Valuation |
---|---|---|---|---|---|
#1 | $15.3M | 109 | -42% | $106.2M | N/A |
What Is WaveForm Diabetes (formerly AgaMatrix Holdings)?
AgaMatrixÔ is a consumer medical device company headquartered in Salem, New Hampshire that develops and manufactures next generation blood glucose monitoring products for the diabetes market. The Company\'s proprietary WaveSenseÔ platform, a suite of biosensor and Dynamic ElectrochemicalÔ technologies, enables high accuracy glucose sensing. Current products include a meter and strip system; future products include a cartridge-based system that fully integrates lancets and sensors.
keywords:N/A$152.2M
Total Funding
122
Number of Employees
$30.6M
Revenue (est)
0%
Employee Growth %
N/A
Valuation
N/A
Accelerator
WaveForm Diabetes (formerly AgaMatrix Holdings) News
The diabetes diagnostic-focused AgaMatrix has secured a capital raise of about $56 million, with plans to support clinical trials of a continuous glucose monitoring system being developed under its WaveForm Technologies subsidiary. Sponsored by Agilent Technologies How would you like to win fr ...
Share Share on Facebook Share on Twitter LinkedIn Email Reprints Misfit Wearables cofounder and CEO Sonny Vu learned a valuable lesson at his last company, AgaMatrix. The mobile health startup produced a blood glucose meter called the iBGStar, which allows users to check, monitor and share thei ...
Company Name | Revenue | Number of Employees | Employee Growth | Total Funding |
---|---|---|---|---|
#1 | $40.3M | 122 | 5% | N/A |
#2 | $33.2M | 123 | -2% | N/A |
#3 | $19.1M | 123 | 10% | N/A |
#4 | $34M | 126 | 12% | N/A |
#5 | $41.9M | 127 | 6% | N/A |